Ophthalmoplegia: Clinical Trials

189 trials for Ophthalmoplegia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

95 completed, 37 recruiting, 22 unknown, 11 active not recruiting. 45 Not applicable, 33 Phase 2, 23 Phase 1, 10 Phase 3, 8 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable45Completed 20, Recruiting 10, Terminated 4, Unknown 4, Active not recruiting 3, Not yet recruiting 2, Enrolling by invitation 1, Withdrawn 1
Phase 233Completed 15, Unknown 6, Terminated 4, Recruiting 3, Enrolling by invitation 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 123Completed 18, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 310Completed 7, Terminated 2, Recruiting 1
Early Phase 18Completed 7, Recruiting 1
Phase 43Completed 3

Follow Ophthalmoplegia: new trials by email Literature Review of Ophthalmoplegia trials Research Report on Ophthalmoplegia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB)
Not yet recruitingBioSensics602027-01-152026-10-13
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary Tauopathies
NIO752, Placebo - Progressive Supranuclear Palsy, Corticobasal Degeneration
Phase 2Not yet recruitingNovartis Pharmaceuticals482026-10-232026-10-09
Study Evaluating the Effect of Transcranial Direct Current Stimulation (tDCS) Targeting the Right Inferior Frontal Gyrus on Inhibitory Control in Patients With PSP
tDCS, or transcranial direct current stimulation - PSP - Progressive Supranuclear Palsy
Not applicableNot yet recruitingNantes University Hospital202026-09-152026-09-14
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Tributyrin, Placebo - Parkinson Disease, Multiple System Atrophy
Phase 1 / Phase 2RecruitingPrabesh Kanel152026-09-012026-10-07
VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and Parkinsonism
Multimodal visuospatial and topographical memory assessment - Parkinson's Disease, Parkinsonism
Not yet recruitingIRCCS San Raffaele Roma802026-09-012026-09-18
Remote Monitoring in Progressive Supranuclear Palsy (PSP)
Progressive Supranuclear Palsy, Parkinson Disease
Not yet recruitingMassachusetts General Hospital852026-09-012026-07-29
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
LM11A-31, Matching Placebo - PSP - Progressive Supranuclear Palsy
Phase 2Enrolling by invitationAdam Boxer1472026-07-292026-08-12
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
AADvac1, Matching Placebo - PSP - Progressive Supranuclear Palsy
Phase 2Enrolling by invitationAdam Boxer1462026-07-292026-08-13
The Progressive Supranuclear Palsy Clinical Trial Platform
AADvac1, LM11A-31 - Progressive Supranuclear Palsy(PSP)
Phase 2RecruitingAdam Boxer4402026-07-292026-10-22
Prospective Natural History Study of POLG Disease
PolG, Primary Mitochondrial Myopathy
RecruitingThe POLG Foundation3002026-06-172026-09-15
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Not yet recruitingInternational Institute of Molecular and Cell Biology in Warsaw2002026-06-042026-05-28
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NIO752, Placebo - Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Phase 3RecruitingNovartis Pharmaceuticals3002026-06-032026-10-15
Wellness in PSP and CBD
Exercise and Peer Support - Progressive Supranuclear Palsy, Corticobasal Degeneration
Not applicableRecruitingSilke Cresswell302026-04-102026-09-28
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
UHR PET/CT scan of the brain with ¹⁸F-FDG, UHR PET/CT scan of the brain with ¹⁸F-PE2I, UHR PET/CT scan of the brain with ¹⁸F-SynVesT-1 - Alzheimer Dementia (AD), ALS - Amyotrophic Lateral Sclerosis
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven3002026-02-132026-04-03
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
TMS - Parkinson's Disease, Multiple System Atrophy
Not applicableRecruitingPeking University First Hospital502025-12-222026-06-29
Biofluid Research on Age-Related or Inherited Neurodegeneration
Frontotemporal Degeneration (FTD), ALS (Amyotrophic Lateral Sclerosis)
RecruitingUniversity of Pennsylvania10002025-12-122026-09-01
First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain
[18F]ABBV-964i, [18F]ABBV-965i, Lead Candidate - Progressive Supranuclear Palsy (PSP), Healthy Participants
Early Phase 1CompletedInvicro112025-11-172026-07-10
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
We did not apply any interventions; only observational research was conducted. - Multiple System Atrophy, Dementia With Lewy Bodies (DLB)
RecruitingSecond Affiliated Hospital of Soochow University5002025-11-122026-09-08
tDCS as Treatment for Motor Function
Transcranial direct current stimulation (TDCS), Stimulation Arm - Progressive Supranuclear Palsy, Cortical Basal Ganglionic Degeneration
Not applicableRecruitingBaycrest202025-10-302025-12-18
Collection of Digital Parameters From Parts of the Neurological Examination Using an Eye Tracker
Geriatric, Parkinsons Disease (PD)
Not yet recruitingUniversity of Kiel6002025-08-312025-08-26

Showing 20 of 189. Sign in to see all of them.

Narrower conditions

Supranuclear Palsy, Progressive (170)  ·  Parkinson Disease (63)  ·  Multiple System Atrophy (55)  ·  Corticobasal Degeneration (49)  ·  Lewy Body Disease (27)  ·  Alzheimer Disease (26)  ·  Parkinsonian Disorders (25)  ·  Frontotemporal Dementia (18)  ·  Amyotrophic Lateral Sclerosis (13)  ·  Ophthalmoplegia, Chronic Progressive External (12)  ·  Pick Disease of the Brain (12)  ·  Neurodegenerative Diseases (11)  ·  Tauopathies (11)  ·  Dementia (10)  ·  Frontotemporal Lobar Degeneration (8)

Broader conditions

Cranial Nerve Diseases (189)  ·  Eye Diseases (189)  ·  Neurologic Manifestations (189)  ·  Ocular Motility Disorders (189)  ·  Paralysis (189)  ·  Pathological Conditions, Signs and Symptoms (189)  ·  Signs and Symptoms (189)  ·  Nervous System Diseases (187)  ·  Central Nervous System Diseases (182)  ·  Brain Diseases (179)  ·  Basal Ganglia Diseases (170)  ·  Neurodegenerative Diseases (164)  ·  Movement Disorders (163)  ·  Tauopathies (159)

Interventions

Observation (4)  ·  Transcranial Direct Current Stimulation (4)  ·  florbetapir (4)  ·  Transcranial Magnetic Stimulation (3)  ·  coenzyme Q10 (3)  ·  gosuranemab (3)  ·  tilavonemab (3)  ·  ((18)F)PI-2620 (2)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (2)  ·  AADvac1 (2)  ·  Blood Specimen Collection (2)  ·  Cysteamine (2)  ·  LM11A-31 (2)  ·  Physical Therapy Modalities (2)  ·  Rivastigmine (2)

Sponsors

University of California, San Francisco (8)  ·  University of Pennsylvania (5)  ·  Adam Boxer (4)  ·  IRCCS San Raffaele Roma (4)  ·  Massachusetts General Hospital (4)  ·  Molecular NeuroImaging (4)  ·  AbbVie (3)  ·  Assistance Publique Hopitaux De Marseille (3)  ·  Biogen (3)  ·  Fondation Ophtalmologique Adolphe de Rothschild (3)  ·  Invicro (3)  ·  Mayo Clinic (3)  ·  Nantes University Hospital (3)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (3)  ·  Novartis Pharmaceuticals (3)

Countries

United States (95)  ·  Germany (24)  ·  Italy (24)  ·  France (23)  ·  United Kingdom (22)  ·  Canada (15)  ·  Spain (14)  ·  China (9)  ·  Australia (7)  ·  Netherlands (7)  ·  Belgium (6)  ·  South Korea (6)  ·  Japan (5)  ·  Austria (4)  ·  Poland (4)

Top investigators

Adam Boxer, MD, PhD (8)  ·  Irene Litvan, MD (4)  ·  Anne-Marie Wills, MD (3)  ·  Julio Rojas-Martinez, MD, PhD (3)  ·  Adam L Boxer, MD, PhD (2)  ·  Andrea Pilotto, MD (2)  ·  Andrew Stephens, MD, PhD (2)  ·  Danna Jennings, MD (2)  ·  Diana Apetauerova, MD (2)  ·  Florin Gandor, MD (2)  ·  Giuseppe Frazzitta, MD (2)

Results publications

PMID 38825840, PMID 28436538, PMID 35790423, PMID 17784944, PMID 19029129, PMID 19771175, PMID 21386111, PMID 21829612, PMID 23017648, PMID 23550093, PMID 23706025, PMID 24438512, PMID 24860459, PMID 24873720, PMID 26469868, PMID 26881179, PMID 27136096, PMID 27160012, PMID 27231659, PMID 27583276, PMID 28158197, PMID 29973911, PMID 31122495, PMID 31325988, PMID 31621619, PMID 31710340, PMID 32078894, PMID 33609476, PMID 33649343, PMID 33827960, PMID 33894193, PMID 34006157, PMID 34232829, PMID 34289275, PMID 34385707, PMID 34489348, PMID 34712113, PMID 34736158, PMID 34934801, PMID 34937781, PMID 35410449, PMID 35492244, PMID 37838080, PMID 37955923, PMID 38082255, PMID 38563872, PMID 38578117, PMID 38692728, PMID 38959435, PMID 39344233

NIH funding

2016 (3), R01AG085029 (3), 2017 (2), P01AG066597 (2), 1UF1AG094587-01 (1), 2008 (1), 2019 (1), 2023 (1), K23NS121402 (1), KL2TR002370 (1), P2CHD086844 (1), P30AG072979 (1), P50NS123067 (1), R01AG024040 (1), R01AG031278 (1)